Adnan A Bekhit

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Venues

Nanomedicine (London, England)

ChemMedChem

Journal of enzyme inhibition and medicinal chemistry

RSC advances

Alexandria University Faculty of Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Alexandria University Faculty of Pharmacy Apr 27 1990 - Apr 27 1993

Egypt

PHD :: Pharmaceutical Chemistry

Alexandria University Faculty of Pharmacy - Dec 29 1989

Egypt

MSC :: Pharmaceutical Chemistry

Publications

Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) 17 (22) (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) 17 (22) (2023)
Riham M Abdelgalil, Yomna M Elmorshedy, Kadria A Elkhodairy, Mohamed Teleb, Adnan A Bekhit, Sherine N Khattab, Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy. Nanomedicine (London, England) 17 (22) (2023)
Adnan A Bekhit, Eskedar T Lodebo, Ariaya Hymete, Hanan M Ragab, Salma A Bekhit, Kikuko Amagase, Afnan Batubara, Mohammed A S Abourehab, Alaa El-Din Ahmed Bekhit, Tamer M Ibrahim
New pyrazolylpyrazoline derivatives as dual acting antimalarial-antileishamanial agents: synthesis, biological evaluation and molecular modelling simulations. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Moaaz T Hamed, Basant A Bakr, Yahya H Shahin, Bassma H Elwakil, Marwa M Abu-Serie, Faizah S Aljohani, Adnan A Bekhit
Novel Synthesis of Titanium Oxide Nanoparticles: Biological Activity and Acute Toxicity Study. Bioinorganic chemistry and applications 2021 (2021)
Mounir A A Mohamed, Adnan A Bekhit, Omyma A Abd Allah, Asmaa M Kadry, Tamer M Ibrahim, Salma A Bekhit, Kikuko Amagase, Ahmed M M El-Saghier
Synthesis and antimicrobial activity of some novel 1,2-dihydro-[1,2,4]triazolo[1,5- a ]pyrimidines bearing amino acid moiety. RSC advances 11 (5) (2021)
Yosra S R Elnaggar, Bassma H Elwakil, Salma S Elshewemi, Moustafa Y El-Naggar, Adnan A Bekhit, Zakia A Olama
Novel Siwa propolis and colistin-integrated chitosan nanoparticles: elaboration; in vitro and in vivo appraisal. Nanomedicine (London, England) (2020)
Sherine N Khattab, Hosam H Khalil, Adnan A Bekhit, Mohamed M Abd El-Rahman, Beatriz G de la Torre, Matti Haukka, Fernando Albericio
1,3,5-Triazino Peptide Derivatives: Synthesis, Characterization, and Preliminary Antileishmanial Activity. ChemMedChem 13 (7) (2018)

Adnan A Bekhit.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Adnan A Bekhit